Progyny, Inc. Common Stock
PGNY Real Time Price USDRecent trades of PGNY by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PGNY's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Apparatus, method, and system for image-based human embryo cell classification Jul. 18, 2017
-
Patent Title: Apparatus, method, and system for automated, non-invasive cell activity tracking Jan. 10, 2017
-
Patent Title: Apparatus, method, and system for the automated imaging and evaluation of embryos, oocytes and stem cells Nov. 01, 2016
-
Patent Title: Apparatus, method, and system for image-based human embryo cell classification Nov. 03, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of PGNY in WallStreetBets Daily Discussion
Recent insights relating to PGNY
Recent picks made for PGNY stock on CNBC
ETFs with the largest estimated holdings in PGNY
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PGNY Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.